Schwartz Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

Schwartz Investment Counsel’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,936	Closed	-$362K	–	147
2021 Q4	$362K	Hold	2,936	–	–	0.01%	125
2021 Q3	$417K	Hold	2,936	–	–	0.02%	114
2021 Q2	$458K	Sell	2,936 -25,750	-90%	-$4.17M	0.02%	112
2021 Q1	$4.46M	Sell	28,686 -427,141	-94%	-$66.2M	0.19%	66
2020 Q4	$68.2M	Sell	455,827 -67,774	-13%	-$9.57M	3.09%	9
2020 Q3	$69.2M	Sell	523,601 -10,300	-2%	-$1.35M	3.49%	5
2020 Q2	$61.9M	Sell	533,901 -15,965	-3%	-$1.84M	3.36%	5
2020 Q1	$54M	Buy	549,866 +47,895	+10%	+$6.28M	3.59%	4
2019 Q4	$72.9M	Sell	501,971 -1,545	-0.3%	-$213K	3.45%	1
2019 Q3	$67.1M	Buy	503,516 +13,905	+3%	+$1.8M	3.41%	3
2019 Q2	$56M	Buy	489,611 +4,635	+1%	+$543K	2.87%	6
2019 Q1	$60.1M	Hold	484,976	–	–	3.22%	3
2018 Q4	$48.8M	Sell	484,976 -25,750	-5%	-$2.9M	3.01%	3
2018 Q3	$65.2M	Buy	510,726 +25,750	+5%	+$3.06M	3.47%	2
2018 Q2	$52.5M	Sell	484,976 -36,050	-7%	-$3.92M	3%	3
2018 Q1	$55.2M	Buy	521,026 +61,800	+13%	+$7.18M	3.25%	2
2017 Q4	$53.8M	Buy	459,226 +10,300	+2%	+$1.16M	3.19%	4
2017 Q3	$51M	Hold	448,926	–	–	3.19%	3
2017 Q2	$56M	Buy	448,926 +10,867	+2%	+$1.29M	3.59%	1
2017 Q1	$51.9M	Buy	438,059 +110,828	+34%	+$12.6M	3.4%	2
2016 Q4	$32.8M	Buy	327,231 +144,921	+79%	+$15.5M	2.28%	12
2016 Q3	$23M	Buy	+182,310	New	+$22.5M	1.64%	24

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schwartz Investment Counsel's ZBH Position: Q1 2022 in Review

Schwartz Investment Counsel sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 2,936 shares — an estimated $362K sold.

Schwartz Investment Counsel first reported a position in ZBH in Q3 2016 and held it in 22 quarters. The position peaked at $72.9M in Q4 2019. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Schwartz Investment Counsel reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Schwartz Investment Counsel sold 2,936 Zimmer Biomet shares in Q1 2022, an estimated $362K.
Schwartz Investment Counsel first reported a position in Zimmer Biomet in Q3 2016 and held it in 22 quarters.
Schwartz Investment Counsel's Zimmer Biomet position peaked at $72.9M in Q4 2019.
978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Schwartz Investment Counsel's 13F filing for Q1 2022, filed 12 May 2022.